Tri-(PEG1-C2-acid) - CAS 1381861-95-5

Purpose of review:The evolution of cardiac catheterization has led to the development of well-refined, more effective, and safer devices that allow cardiovascular interventionalists to deliver high-quality percutaneous interventions (PCI). Transradial PCI (TRI) has gained more popularity in the USA over the past 10 years, and as experience and volume of TRI grow, studies adopting same day radial PCI protocols have emerged and are showing promising results. We sought to review the current literature on TRI and same day discharge (SDD).Recent findings:This literature review was performed to evaluate the studies that were published over the last 17 years regarding TRI and SDD. A literature search using PubMed, Cochran database, Google Scholar, and Embase was performed for studies evaluating TRI and SDD from January 1, 2000, to August 1, 2017. Observational studies, randomized clinical trials, meta-analyses, and consensus statements were included in our review. We used the following terms in our search: "same day," "same day discharge," "outpatient," and "ambulatory radial PCI." Articles with data pertinent to the subject matter were included. We did not limit our searches to specific journals. The available literature supports SDD for selected radial PCI patients. The advancement in PCI devices and pharmacology has enhanced the safety of post-PCI disposition leading to the evolution from traditional overnight stays to the development of same day discharge programs. We conclude that outpatient TRI for appropriately selected patients will be the standard of care in the future. This will lead to increased patient satisfaction, improved hospital throughput, and reduced hospital costs, without increased procedural complications.

The interest of organoboron chemistry in organic synthesis is growing, together with the development of new and versatile polyborated reagents. Here, the preparation of 1,1,1-tri(boryl)alkanes, 1,2,3-tri(boryl)alkanes, 1,1,2-tri(boryl)alkanes, as well as 1,1,2-tri(boryl)alkenes as suitable and accessible polyborated systems is demonstrated as being easily applied in the construction of new carbon-carbon and carbon-heteroatom bonds. Synthetic procedures and limitations have been collected to demonstrate the powerful strategies to construct selective molecules, taking advantages of the easy transformation of carbon-boron bond in multiple functionalities, under the total control of chemo- and stereoselectivity.

Tri-tert-butylphosphatetrahedrane (1) is shown here to act as a synthon of isomeric tri-tert-butylphosphacyclobutadiene in the presence of a Lewis acid or transition-metal complex. When it is combined with a substoichiometric amount of triphenylborane, compound 1 forms a ladderane-type dimer of tri-tert-butylphosphacyclobutadiene in 72% isolated yield. Trapping of a generated intermediate was achieved by repeating the experiment in the presence of excess styrene (20 equiv) or ethylene (1 atm), and the corresponding [4 + 2] cycloadducts of tri-tert-butylphosphacyclobutadiene were isolated in 88% and 74% yields, respectively. The platinum complex (Ph3P)2Pt(C2H4) also reacts with 1 to form an orange η2 complex of tri-tert-butylphosphacyclobutadiene in 80% isolated yield. Additionally, we report a novel method for generating a phosphinidenoid species via fluoride-induced trimethylsilyl fluoride elimination, leading to an improved preparative procedure for 1 (182 mg, 33% isolated yield).